Treatment of superficial mycoses: review. Part II
Open accessThe DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Abstract
Superficial fungal infections of the hair, skin and nails are a major cause of morbidity in the world. Choosing the right treatment is not always simple because of the possibility of drug interactions and side effects. The first part of the article discusses the main treatments for superficial mycoses - keratophytoses, dermatophytosis, candidiasis, with a practical approach to the most commonly-used topical and systemic drugs , referring also to their dosage and duration of use. Promising new, antifungal therapeutic alternatives are also highlighted, as well as available options on the Brazilian and world markets.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Rook's Textbook of Dermatology
(2010) · Wiley eBooks · doi:10.1002/9781444317633 · Cited by 911
Update in Antifungal Therapy of Dermatophytosis
Gupta, A. K., & Cooper, E. A. (2008) · Mycopathologia · doi:10.1007/s11046-008-9109-0 · Cited by 329
Chen, S. C. A., & Sorrell, T. C. (2007) · Medical Journal of Australia · doi:10.5694/j.1326-5377.2007.tb01313.x · Cited by 175
Gupta, A. K., & Kohli, Y. (2003) · British Journal of Dermatology · doi:10.1046/j.1365-2133.2003.05418.x · Cited by 168
Treatment options – development of consensus guidelines
Lecha, M., Effendy, I., de Chauvin, M. F., Chiacchio, N. G. D., & Baran, R. (2005) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/j.1468-3083.2005.01284.x · Cited by 141
Croxtall, J. D., & Plosker, G. L. (2009) · Drugs · doi:10.2165/00003495-200969030-00009 · Cited by 133
In vitro antifungal activities of luliconazole, a new topical imidazole
Koga, H., Nanjoh, Y., Makimura, K., & Tsuboi, R. (2009) · Medical Mycology · doi:10.1080/13693780802541518 · Cited by 132
Drug interactions with itraconazole, fluconazole, and terbinafine and their management
Gupta, A. K., Katz, H. I., & Shear, N. H. (1999) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(99)70055-1 · Cited by 111
Advances in Topical and Systemic Antifungals
Zhang, A. Y., Camp, W. L., & Elewski, B. E. (2007) · Dermatologic Clinics · doi:10.1016/j.det.2007.01.002 · Cited by 108
Onychomycosis: current treatment and future challenges
Roberts, D. T. (1999) · British Journal of Dermatology · doi:10.1046/j.1365-2133.1999.00007.x · Cited by 101
In vitro antifungal activity of luliconazole (NND-502), a novel imidazole antifungal agent
Uchida, K., Nishiyama, Y., & Yamaguchi, H. (2004) · Journal of Infection and Chemotherapy · doi:10.1007/s10156-004-0327-1 · Cited by 91
Novel triazole antifungal drugs: focus on isavuconazole, ravuconazole and albaconazole.
Pasqualotto, A. C., Thiele, K. O., & Goldani, L. Z. (2010) · PubMed · Cited by 90
Squire, R., & Goode, K. (2002) · Journal of Dermatological Treatment · doi:10.1080/095466302317584395 · Cited by 83
Oral therapy of common superficial fungal infections of the skin
Lesher, J. L. (1999) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(99)70395-6 · Cited by 73
Efficacious Treatment of Non-Dermatophyte Mould Onychomycosis with Topical Amphotericin B
Lurati, M., Baudraz-Rosselet, F., Vernez, M., Spring, P., Bontems, O., Fratti, M., & Monod, M. (2011) · Dermatology · doi:10.1159/000335093 · Cited by 64
In vitro activity of novel imidazole antifungal agent NND-502 against Malassezia species
Uchida, K., Nishiyama, Y., Tanaka, T., & Yamaguchi, H. (2003) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(02)00362-x · Cited by 57
Dermatology in General Medicine
Lazar, P. (1980) · Archives of Dermatology · doi:10.1001/archderm.1980.01640310116035 · Cited by 56
Türel, Ö. (2011) · Expert Review of Anti-infective Therapy · doi:10.1586/eri.10.163 · Cited by 49
Original Article: Superficial cutaneous fungal infections in tropical countries
Charles, A. J. (2009) · Dermatologic Therapy · doi:10.1111/j.1529-8019.2009.01276.x · Cited by 49
Butenafine and superficial mycoses: current status
Singal, A. (2008) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.4.7.999 · Cited by 41
The hydroxypyridones: a class of antimycotics of its own
Korting, H. C., & Grundmann‐Kollmann, M. (1997) · Mycoses · doi:10.1111/j.1439-0507.1997.tb00227.x · Cited by 39
Eberconazole - Pharmacological and clinical review
Moodahadu, L., Martis, J., Mittal, R., Krishnankutty, B., Kumar, N., Bellary, S., Varughese, S., & Rao, P. (2012) · Indian Journal of Dermatology Venereology and Leprology · doi:10.4103/0378-6323.93651 · Cited by 35
Ghannoum, M. A., Long, L., Kim, H. G., Cirino, A. J., Miller, A. R., & Mallefet, P. (2010) · Medical Mycology · doi:10.3109/13693780903373811 · Cited by 35
Making sense of posaconazole therapeutic drug monitoring: a practical approach
Ananda-Rajah, M. R., Grigg, A., & Slavin, M. A. (2012) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0b013e328359a56e · Cited by 34
Rubin, A. I., Bagheri, B., & Scher, R. K. (2002) · American Journal of Clinical Dermatology · doi:10.2165/00128071-200203020-00001 · Cited by 34
Overview: The treatment of dermatophytosis
Rand, S. (2000) · Journal of the American Academy of Dermatology · doi:10.1067/mjd.2000.110380 · Cited by 33
Repiso, T., López, S., Rodríguez, C., del Río, R., Badell, A., & Mr, G. (2006) · International Journal of Dermatology · doi:10.1111/j.1365-4632.2006.02841.x · Cited by 25
Contact dermatitis due to lanoconazole, cetyl alcohol and diethyl sebacate in lanoconazole cream
Soga, F., Katoh, N., & Kishimoto, S. (2004) · Contact Dermatitis · doi:10.1111/j.0105-1873.2004.00271j.x · Cited by 22
Das, S., Barbhuniya, J., Biswas, I., Bhattacharya, S., & Kundu, P. K. (2010) · Indian Dermatology Online Journal · doi:10.4103/2229-5178.73249 · Cited by 22
Antifungal susceptibilities of dermatophytic agents isolated from clinical specimens.
Çetınkaya, Z., Kiraz, N., Karaca, Ş., Kulaç, M., Çiftçi, İ. H., Aktepe, O. C., Altındiş, M., Kiyildi, N., & Piyade, M. (2005) · PubMed · Cited by 18
Keshtkar‐Jahromi, M., McTighe, A. H., Segalman, K. A., Fothergill, A. W., & Campbell, W. N. (2012) · Mycopathologia · doi:10.1007/s11046-012-9540-0 · Cited by 17
Sigle, H.-C., Schäfer‐Korting, M., Körting, H. C., Hube, B., & Niewerth, M. (2006) · Mycoses · doi:10.1111/j.1439-0507.2006.01228.x · Cited by 12
Comparison of thein vitroactivity of terbinafine and lanoconazole against dermatophytes
Ghannoum, M. A., Welshenbaugh, A. R., Imamura, Y., Isham, N. C., Mallefet, P., & YAMAGUCHI, H. (2009) · Mycoses · doi:10.1111/j.1439-0507.2009.01723.x · Cited by 12
Neues zu Diagnostik und Therapie bei Mykosen der Haut
Brasch, J. (2012) · Der Hautarzt · doi:10.1007/s00105-011-2259-x · Cited by 10
In vitro Susceptibility Testing of Malassezia furfur against Rilopirox
Nenoff, P., & Haustein, U. (2009) · Skin Pharmacology · doi:10.1159/000211515 · Cited by 10
Interaction between amorolfine and acenocoumarol
Morales-Molina, J. A., Fayet-Pérez, A., Martínez-Plata, E., Pérez-Moyano, R., & Arrebola, M. A. M. (2012) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-012-1305-7 · Cited by 6
Research works printed but not linked: 9
- Verma S, 2008, Superficial fungal infection: dermatophytosis, tinea nigra, piedra, 1807
- Hay RJ, 2010, Superficial mycoses, 36.5
- Sobera JO, 2008, Fungal diseases, 1135
- Murray PR, 1994, Superficial, cutaneous and subcutaneous mycosis, 404
- Hardman JG, 2003, Agentes Antifúngicos (Antifungal Agents)
- Azulay RD, 2011, Micoses superficiais (Superficial Mycoses), 419
- Ramos-e-Silva M, 2010, Micoses superficiais (Superficial Mycoses), 879
- Brasch J, 2012, New aspects in the diagnosis and therapy of dermatomycoses, Hautarzt, 63, 390
- Ghannoum MA, 2010, Comparison of the in vitro activity of terbinafine and lanoconazole against dermatophytes, Mycoses, 53, 311
Cited by
Luliconazole for the treatment of fungal infections: an evidence-based review
Khanna, D., & Bharti, S. (2014) · Core evidence · doi:10.2147/ce.s49629 · Cited by 146
Lara, H. H., Guisbiers, G., Mendoza, J., Mimun, L. C., Vincent, B., Lopez-Ribot, J. L., & Nash, K. L. (2018) · International Journal of Nanomedicine · doi:10.2147/ijn.s151285 · Cited by 104
“…selenium nanoparticles (seNPs) As selenium (Se) sulfide is used in the treatment of superficial mycoses in the form of a topical antifungal shampoo 18 and SeNPs have demonstrated fungicidal effects against C. albicans biofilms, 19 we decided to test pure SeNPs in combination with chitosan (CS) or…”
Vlaia, L. L., Coneac, G. H., Muț, A. M., Olariu, I. V., Vlaia, V., Anghel, D. F., Maxim, M. E., Dobrescu, A., Hîrjău, M., & Lupuleasa, D. (2021) · Processes · doi:10.3390/pr9010144 · Cited by 41
Emerging Trends in the Use of Topical Antifungal-Corticosteroid Combinations
Mijaljica, D., Spada, F., & Harrison, I. P. (2022) · Journal of Fungi · doi:10.3390/jof8080812 · Cited by 38
Pandya, P. A., Shah, P. A., & Shrivastav, P. S. (2020) · Journal of Chromatography A · doi:10.1016/j.chroma.2020.461299 · Cited by 27
Metadata
- Authors
- Dias, M. F. R. G., Bernardes-Filho, F., Quaresma-Santos, M. V. P., Amorim, A. G. D. F., Schechtman, R. C., & Azulay, D. R.
- Affiliations
- Santa Casa da Misericórdia do Rio de Janeiro, Brazil
- University of London (GB)
- Universidade Federal do Rio de Janeiro (BR)
- Corresponding author
- Dias, Maria Fernanda Reis Gavazzoni
- Venue
- Anais Brasileiros de Dermatologia
- Publisher
- FapUNIFESP (SciELO)
- Published
- 2013-12
- Volume
- 88
- Issue
- 6
- Pages
- 937-944
- ISSN
- 0365-0596 (ISSN-L)
- PMC
- PMC3900345
- OpenAlex
- W2058838299
- Cited by
- 42
- References
- 36
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 1 · 2023: 5 · 2022: 5 · 2021: 6 · 2020: 3 · 2019: 2 · 2018: 6 · 2017: 3 · 2016: 1 · 2015: 5 · 2014: 2
- FWCI
- 0.32
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by-nc
- Locations
- Anais Brasileiros de Dermatologia (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (publishedVersion, other-oa)
- Americanae (AECID Library) (submittedVersion, cc-by-nc)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Health Sciences › Medicine › Dermatology › Nail Diseases and Treatments
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Health Sciences › Medicine › Infectious Diseases › Fungal Infections and Studies
- Keywords
- superficial fungal infections, dermatophytosis, candidiasis, antifungal agents, topical antifungal agents, systemic antifungal agents, drug interactions, adverse drug reactions
- MeSH terms
- Antifungal Agents, Dermatomycoses, Drug Interactions, Humans, Time Factors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.